LINK:

OBJECTIVES: Upon completion of this activity, the participant should be able to: 

(1) Recognize available agents for the treatment of malignant brain tumors.

(2) Discuss awareness of molecular findings that predict prognosis and response to treatment.

(3) Recognize imaging findings for high and low-grade gliomas.

Faculty Disclosure: Karen Fink, MD does not have a relevant financial interest or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Planner Disclosure: Jennifer Zimmer, MD does not have a relevant financial interest or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

For assistance please contact Jamie Davidson at [email protected]